PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
17-Jun-2024 CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations CluePoints
17-Jun-2024 Instem And Proscia Partner To Accelerate Preclinical Development With Digital Pathology Proscia
12-Jun-2024 $8 million seed investment round turbocharges IgniteData’s growth IgniteData
12-Jun-2024 CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT CluePoints
12-Jun-2024 BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patients BellaSeno GmbH
11-Jun-2024 https://www.ignitedata.com/8-million-seed-investment-round-turbocharges-ignitedatas-growth/ IgniteData
11-Jun-2024 CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints
11-Jun-2024 Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System Amber Implants
10-Jun-2024 Meril Announces Prestigious LANCET Publication for Landmark RCT of the MYVAL THV Series, Researched and Developed by INDIA Meril Life Sciences
07-Jun-2024 New US headquarters opened by mass photometry pioneers Refeyn Refeyn
07-Jun-2024 PureTech Result of General Meeting PureTech Health plc
07-Jun-2024 iMM Joins the MAGIC Consortium to Advance Research on Muscular Dystrophies The MAGIC Consortium
07-Jun-2024 16th Edition Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs Conference marcus evans
06-Jun-2024 Major cause of inflammatory bowel disease discovered The Francis Crick Institute
06-Jun-2024 Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation Beckman Coulter Life Sciences
06-Jun-2024 Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments Clinigen
06-Jun-2024 KITE RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL OF SAFETY MONITORING VARIATION FOR CAR T-CELL THERAPY PORTFOLIO Gilead Sciences
06-Jun-2024 Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundation Alchemab
06-Jun-2024 CYCLE PHARMACEUTICALS ANNOUNCES ALL-CASH PROPOSAL TO ACQUIRE VANDA PHARMACEUTICALS FOR $8.00 PER SHARE Cycle Pharmaceuticals
06-Jun-2024 FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning CluePoints